(RMAX) Re Max Holding - Overview
Stock: Franchise, Mortgage, Software, Platform, Education
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 44.8% |
| Relative Tail Risk | -6.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.64 |
| Alpha | -43.40 |
| Character TTM | |
|---|---|
| Beta | 0.984 |
| Beta Downside | 0.954 |
| Drawdowns 3y | |
|---|---|
| Max DD | 68.29% |
| CAGR/Max DD | -0.45 |
Description: RMAX Re Max Holding December 30, 2025
RE/MAX Holdings, Inc. (NYSE:RMAX) is a global franchisor of real-estate brokerage services, operating under the RE/MAX brand in the U.S., Canada, and other markets. Its business is divided into three segments: Real Estate (franchise fees and royalty income), Mortgage (Motto Mortgage brokerage and wemlo loan-processing technology), and Marketing Funds (advertising and lead-generation platforms such as BoldTrail). The company also runs RE/MAX University, an online training hub for agents. Founded in 1973 and headquartered in Denver, Colorado, RE/MAX leverages a network of over 8,300 offices and more than 140,000 agents worldwide.
Key recent metrics: FY 2023 revenue reached $1.09 billion, a 7% YoY increase driven primarily by a 9% rise in franchise royalty fees and higher average unit volume (AUV) per office. The Mortgage segment contributed roughly 12% of total revenue, reflecting growing demand for integrated brokerage-mortgage solutions. Macro-driven factors such as the U.S. housing market’s modest rebound after the 2023 rate-hike cycle and a continued shortage of inventory support transaction volume, while rising interest rates could compress mortgage-related margins.
For a deeper quantitative view, check the ValueRay dashboard for RMAX to explore granular performance trends and valuation models.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 12.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.77 > 1.0 |
| NWC/Revenue: 31.60% < 20% (prev 17.38%; Δ 14.22% < -1%) |
| CFO/TA 0.08 > 3% & CFO 44.7m > Net Income 12.5m |
| Net Debt (355.3m) to EBITDA (70.8m): 5.02 < 3 |
| Current Ratio: 1.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (20.7m) vs 12m ago 6.15% < -2% |
| Gross Margin: 74.76% > 18% (prev 0.72%; Δ 7405 % > 0.5%) |
| Asset Turnover: 50.47% > 50% (prev 53.89%; Δ -3.42% > 0%) |
| Interest Coverage Ratio: 1.36 > 6 (EBITDA TTM 70.8m / Interest Expense TTM 32.5m) |
Altman Z'' 0.62
| A: 0.16 (Total Current Assets 235.3m - Total Current Liabilities 142.7m) / Total Assets 582.2m |
| B: -0.22 (Retained Earnings -127.4m / Total Assets 582.2m) |
| C: 0.08 (EBIT TTM 44.1m / Avg Total Assets 580.4m) |
| D: -0.21 (Book Value of Equity -128.1m / Total Liabilities 617.1m) |
| Altman-Z'' Score: 0.62 = B |
Beneish M -2.96
| DSRI: 1.30 (Receivables 39.3m/32.3m, Revenue 292.9m/311.8m) |
| GMI: 0.96 (GM 74.76% / 71.53%) |
| AQI: 0.93 (AQ_t 0.56 / AQ_t-1 0.60) |
| SGI: 0.94 (Revenue 292.9m / 311.8m) |
| TATA: -0.06 (NI 12.5m - CFO 44.7m) / TA 582.2m) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of RMAX shares?
Over the past week, the price has changed by -4.88%, over one month by -4.27%, over three months by -1.86% and over the past year by -28.36%.
Is RMAX a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the RMAX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9 | 21.6% |
| Analysts Target Price | 9 | 21.6% |
| ValueRay Target Price | 5.6 | -23.9% |
RMAX Fundamental Data Overview February 03, 2026
P/E Forward = 12.0773
P/S = 1.3982
P/B = 0.3531
P/EG = 4.07
Revenue TTM = 292.9m USD
EBIT TTM = 44.1m USD
EBITDA TTM = 70.8m USD
Long Term Debt = 433.3m USD (from longTermDebt, last quarter)
Short Term Debt = 13.7m USD (from shortTermDebt, last quarter)
Debt = 462.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 355.3m USD (from netDebt column, last quarter)
Enterprise Value = 764.9m USD (409.6m + Debt 462.8m - CCE 107.5m)
Interest Coverage Ratio = 1.36 (Ebit TTM 44.1m / Interest Expense TTM 32.5m)
EV/FCF = 19.45x (Enterprise Value 764.9m / FCF TTM 39.3m)
FCF Yield = 5.14% (FCF TTM 39.3m / Enterprise Value 764.9m)
FCF Margin = 13.42% (FCF TTM 39.3m / Revenue TTM 292.9m)
Net Margin = 4.27% (Net Income TTM 12.5m / Revenue TTM 292.9m)
Gross Margin = 74.76% ((Revenue TTM 292.9m - Cost of Revenue TTM 73.9m) / Revenue TTM)
Gross Margin QoQ = 75.23% (prev 74.88%)
Tobins Q-Ratio = 1.31 (Enterprise Value 764.9m / Total Assets 582.2m)
Interest Expense / Debt = 1.74% (Interest Expense 8.05m / Debt 462.8m)
Taxrate = 33.68% (3.79m / 11.3m)
NOPAT = 29.3m (EBIT 44.1m * (1 - 33.68%))
Current Ratio = 1.65 (Total Current Assets 235.3m / Total Current Liabilities 142.7m)
Debt / Equity = 1.03 (Debt 462.8m / totalStockholderEquity, last quarter 448.1m)
Debt / EBITDA = 5.02 (Net Debt 355.3m / EBITDA 70.8m)
Debt / FCF = 9.04 (Net Debt 355.3m / FCF TTM 39.3m)
Total Stockholder Equity = 438.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.16% (Net Income 12.5m / Total Assets 582.2m)
RoE = 2.86% (Net Income TTM 12.5m / Total Stockholder Equity 438.4m)
RoCE = 5.06% (EBIT 44.1m / Capital Employed (Equity 438.4m + L.T.Debt 433.3m))
RoIC = 3.33% (NOPAT 29.3m / Invested Capital 877.8m)
WACC = 5.09% (E(409.6m)/V(872.4m) * Re(9.54%) + D(462.8m)/V(872.4m) * Rd(1.74%) * (1-Tc(0.34)))
Discount Rate = 9.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.45%
[DCF Debug] Terminal Value 88.29% ; FCFF base≈41.0m ; Y1≈49.8m ; Y5≈81.8m
Fair Price DCF = 101.2 (EV 2.38b - Net Debt 355.3m = Equity 2.03b / Shares 20.1m; r=5.90% [WACC]; 5y FCF grow 22.91% → 2.90% )
EPS Correlation: -67.14 | EPS CAGR: -50.76% | SUE: -4.0 | # QB: 0
Revenue Correlation: -94.45 | Revenue CAGR: -5.11% | SUE: -0.43 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.23 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=1.31 | Chg30d=+0.000 | Revisions Net=-4 | Growth EPS=+1.7% | Growth Revenue=+1.4%